Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.18B | 418.00M | 1.02B | 2.30B | 2.25B |
| Total Depreciation and Amortization | 373.00M | -336.00M | 329.00M | 335.00M | 331.00M |
| Total Amortization of Deferred Charges | -- | 734.00M | -- | -- | -- |
| Total Other Non-Cash Items | 246.00M | -92.00M | 90.00M | -233.00M | 389.00M |
| Change in Net Operating Assets | -1.79B | -18.00M | 1.24B | -1.96B | -988.00M |
| Cash from Operations | 1.02B | 706.00M | 2.68B | 447.00M | 1.98B |
| Capital Expenditure | -196.00M | -322.00M | -332.00M | -323.00M | -279.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -3.69B | 0.00 | -4.00M | -1.12B |
| Divestitures | 4.00M | -36.00M | 0.00 | 399.00M | -- |
| Other Investing Activities | 295.00M | 2.41B | -69.00M | -890.00M | -911.00M |
| Cash from Investing | 103.00M | -1.64B | -401.00M | -818.00M | -2.31B |
| Total Debt Issued | 836.00M | 5.04B | 48.00M | 1.34B | 1.56B |
| Total Debt Repaid | -1.37B | -1.45B | -568.00M | 107.00M | -586.00M |
| Issuance of Common Stock | 23.00M | 16.00M | 48.00M | 60.00M | 97.00M |
| Repurchase of Common Stock | -1.00B | -1.81B | -66.00M | -463.00M | -666.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -386.00M | -373.00M | -378.00M | -378.00M | -379.00M |
| Other Financing Activities | -14.00M | -7.00M | 1.00M | 4.00M | 4.00M |
| Cash from Financing | -1.91B | 1.41B | -915.00M | 668.00M | 32.00M |
| Foreign Exchange rate Adjustments | 1.00M | -8.00M | 7.00M | -5.00M | -- |
| Miscellaneous Cash Flow Adjustments | -- | -46.00M | 1.00M | -21.00M | -- |
| Net Change in Cash | -788.00M | 422.00M | 1.37B | 271.00M | -300.00M |